 |
Return Create A Forum - Home |
 |
--------------------------------------------------------- |
|
MS Speaks |
 |
https://msspeaks.createaforum.com |
|
--------------------------------------------------------- |
|
***************************************************** |
|
Return to: OCREVUS (ocrelizumab) |
|
***************************************************** |
|
#Post#: 3308-------------------------------------------------- |
|
Immune-suppressed patients in Ontario eligible for earlier COVID |
|
-19 vaccine |
|
By: agate Date: June 3, 2021, 1:09 am |
|
--------------------------------------------------------- |
|
This applies to people with MS in Ontario taking Ocrevus, |
|
Rituxan (rituximab), or Kesimpta (ofatumumab): |
|
From CBC News (June 2, 2021)--"More Immune-Suppressed Patients |
|
in Ontario Eligible for Earlier COVID-19 Vaccine": |
|
https://www.cbc.ca/news/canada/kitchener-waterloo/more-immune-suppressed-patien… |
|
***************************************************** |
